Loading organizations...
§ Venture Capital · Lausanne, Vaud, Switzerland
Swiss venture capital fund based in Lausanne, investing in high-tech startups in French-speaking Switzerland.
Initiative Capital Romandie (ICR) is a Swiss venture capital fund based in Lausanne, Switzerland, focused on supporting high-tech startups across French-speaking Switzerland. The fund, managed by DEFI Gestion SA, a Lausanne-based private equity funds advisor, provides capital to early-stage companies within the Romandie region, aiming to foster local innovation and economic development. ICR has actively participated in notable financing rounds for its portfolio companies, including Anergis' CHF 18 million Series A and Endosense's USD 36 million Series B, demonstrating its commitment to scaling promising ventures. Its institutional backing comes from key partners such as Retraites Populaires Vie, Banque Cantonale Vaudoise, Centre Patronal, and Etablissement Cantonal d’Assurance. These four entities collectively founded Initiative Capital Romandie in 2006, establishing its mandate to invest in the region's high-tech ecosystem.
Initiative Capital Romandie has 8 tracked investments across 4 companies. The latest tracked deal is $18.0M Series C in Aleva Neurotherapeutics in May 2016.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 27, 2016 | Aleva Neurotherapeutics | $18.0M Series C | Anthony Borowicz | Banexi Ventures Partners, BB Biotech Ventures, BioMedPartners, Forrestal Capital, Kinled Holding |
| Sep 4, 2015 | Aleva Neurotherapeutics | $16.1M Other Equity | — | Banexi Ventures Partners, BB Biotech Ventures, BioMedPartners |
| Jun 7, 2013 | Diagnoplex | $1.4M Other Equity | Debiopharm Diagnostics | Neomed Management |
| Apr 10, 2012 | Aleva Neurotherapeutics | $4.3M Series B | Sophie Pierrin Lepinard | BB Biotech Ventures, BioMedPartners |
| Aug 31, 2011 | Aleva Neurotherapeutics | $13.7M Series A | Juergen Eckhardt, Markus Hosang | — |
| Jul 1, 2011 | Myopowers Medical Technologies | $16.0M Series B | Philippe Pouletty | Earlybird Venture Capital, Blue Ocean Ventures, DRX Capital, Gran Plasa |
| Jan 18, 2011 | Diagnoplex | $10.4M Series A Extension | Debiopharm | Neomed Management, Novartis |
| Jun 1, 2010 | NanoPowers | $4.3M Series A | DRX Capital | Gran Plasa |